The growth in the use and prevalence of new drugs – such as so-called ‘legal highs’ – across Europe shows no sign of slowing down, with strong evidence indicating that the substances are doing a lot of harm, according to a new EU report.
The EU Drug Markets Report 2016 outlines the dominant trends in the supply and distribution of illicit drugs across Europe.
It is a joint effort by the the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol, the European policing agency.
The report outlines how there is now over 560 “new substances” being monitored by the EMCDDA - more than twice the number of drugs controlled under international drug control conventions.
These are classified as “new psychoactive substances” and are becoming an increasing concern across Europe.
More than 380 of the new drugs currently being monitored were detected in the last year alone.
Source: thejournal.ie